Published in Gut on February 01, 1990
Acid suppression: how much is needed? BMJ (1990) 1.07
Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: a meta-analysis. World J Gastroenterol (2005) 1.03
Optimizing acid suppression for treatment of acid-related diseases. Dig Dis Sci (1995) 0.96
Low dose famotidine and cimetidine in single postprandial doses: a placebo controlled comparative study of overnight pH. Gut (1995) 0.81
pH-feedback controlled infusions of ranitidine are no more effective than fixed-dose infusions in reducing gastric acidity and variability in antisecretory responses. Br J Clin Pharmacol (1992) 0.77
Maintenance of intragastric pH > 4 with famotidine in duodenal ulcer patients: factors influencing drug requirements. Gut (1994) 0.75
Efficacy of proton pump inhibitors and H2 blocker in the treatment of symptomatic gastroesophageal reflux disease in infants. Korean J Pediatr (2016) 0.75
Postprandial biliary and pancreatic secretion during profound inhibition of gastric secretion in humans. Gut (1993) 0.75
Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer. Gut (1983) 4.47
Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut (1987) 2.40
Reduction of twenty-four-hour gastric acidity with combination drug therapy in patients with duodenal ulcer. Gastroenterology (1979) 1.98
Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer. Gut (1988) 1.40
Day-to-day variation of 24-hour intragastric acidity. Gastroenterology (1988) 1.39
Single dose treatment with H2 receptor antagonists: is bedtime administration too late? Gut (1987) 1.29
Comparison of ranitidine 300 mg twice daily, 300 mg at night and placebo on 24-hour intragastric acidity of duodenal ulcer patients. Aliment Pharmacol Ther (1987) 1.16
Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut (1984) 3.18
Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ (1992) 3.17
Effect of daily oral omeprazole on 24 hour intragastric acidity. Br Med J (Clin Res Ed) (1983) 2.30
Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med (1983) 2.10
Wallstents versus plastic stents in malignant biliary obstruction: effects of stent patency of the first and second stent on patient compliance and survival. Am J Gastroenterol (1996) 2.08
Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Br Med J (Clin Res Ed) (1984) 1.61
Vitamin A treatment for night blindness in primary biliary cirrhosis. Br Med J (Clin Res Ed) (1984) 1.57
Comparison of twice-daily ranitidine with standard cimetidine treatment of duodenal ulcer. Gut (1981) 1.50
Influence of prostaglandins, omeprazole, and indomethacin on healing of experimental gastric ulcers in the rat. Gastroenterology (1988) 1.50
Removal of razor blades from stomach with fibreoptic endoscope. Br Med J (1974) 1.50
Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. Br J Pharmacol (1998) 1.44
Effect of repeated oral infection of hamsters with scrapie. J Gen Virol (1998) 1.44
Self-expanding metal stents in malignant esophageal obstruction: a comparison between two stent types. Am J Gastroenterol (1997) 1.42
[Collagen colitis and lymphocytic (microscopic) colitis: different or common origin?]. Z Gastroenterol (1997) 1.41
Effects of oral pantoprazole on 24-hour intragastric acidity and plasma gastrin profiles. Aliment Pharmacol Ther (1992) 1.40
Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer. Gut (1988) 1.40
Day-to-day variation of 24-hour intragastric acidity. Gastroenterology (1988) 1.39
Rising death rate from non-malignant disease of the oesophagus (NMOD) in England and Wales. Gut (1995) 1.32
[Healing rates following omeprazole and ranitidine treatment of gastric ulcer. Results of a German multicenter study]. Dtsch Med Wochenschr (1985) 1.31
Intravenous omeprazole rapidly raises intragastric pH. Gut (1985) 1.31
Single dose treatment with H2 receptor antagonists: is bedtime administration too late? Gut (1987) 1.29
Detection and prevalence of Helicobacter infection in pet cats. J Clin Microbiol (1998) 1.29
Prophylactic endoscopic sclerotherapy of oesophageal varices. A prospective controlled study. Lancet (1985) 1.25
Gastric and duodenal ulcer healing under placebo treatment. Gastroenterology (1977) 1.23
Pattern of 24 hour intragastric acidity in active duodenal ulcer disease and in healthy controls. Gut (1988) 1.22
Diclofenac hepatitis. Br Med J (Clin Res Ed) (1982) 1.22
Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin. BMJ (1989) 1.18
Evaluation of specific value of endoscopic biopsies and brush cytology for malignancies of the oesophagus and stomach. Gut (1976) 1.18
Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin. Am J Physiol (1995) 1.18
Comparison of ranitidine 300 mg twice daily, 300 mg at night and placebo on 24-hour intragastric acidity of duodenal ulcer patients. Aliment Pharmacol Ther (1987) 1.16
Influence of long-term 16,16-dimethyl prostaglandin E2 treatment on the rat gastrointestinal mucosa. Gastroenterology (1983) 1.16
Conversion of serine to aspartate imitates phosphorylation-induced changes in the structure and function of microtubule-associated protein tau. J Biol Chem (1997) 1.15
A national training programme for gastroenterology and hepatology. Gut (1996) 1.14
Oral phenytoin pharmacokinetics during omeprazole therapy. Br J Clin Pharmacol (1987) 1.13
Risk factor assessment of endoscopically removed malignant colorectal polyps. Gut (1998) 1.11
Effects of prolonged metiamide medication on the fundic mucosa. A secretory and histomorphometric study in the rat. Gastroenterology (1977) 1.11
Misoprostol, smoking, and duodenal ulcer healing rates. Lancet (1987) 1.08
Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours. Am J Gastroenterol (1999) 1.06
Transgastric hybrid cholecystectomy. Br J Surg (2009) 1.06
HGF triggers activation of the COX-2 gene in rat gastric epithelial cells: action mediated through the ERK2 signaling pathway. FASEB J (1999) 1.05
Colitis associated with non-steroidal anti-inflammatory drugs. Br Med J (Clin Res Ed) (1984) 1.03
Helicobacter pylori eradication in a clinical setting: success rates and the effect on the quality of life in peptic ulcer. Aliment Pharmacol Ther (1995) 1.03
Gastric mucosal protection with selective inhibition of thromboxane synthesis. Gut (1987) 1.03
Investigations on the penetration of ranitidine into the cerebrospinal fluid and a comparison of the effects of ranitidine and cimetidine on male sex hormones. Scand J Gastroenterol Suppl (1981) 1.02
Roles of hepatocyte growth factor and its receptor Met during gastric ulcer healing in rats. Gastroenterology (1997) 1.02
[Nonsteroidal antirheumatic drugs and acetylsalicylic acid: adverse effects distal to the duodenum]. Schweiz Med Wochenschr (1996) 1.00
Treatment of achalasia with a pneumatic dilator attached to a gastroscope. Endoscopy (1981) 0.99
Precipitation of hepatic encephalopathy by propranolol in cirrhosis. Br Med J (Clin Res Ed) (1983) 0.98
Behaviour of the dying patient. Br Med J (1975) 0.98
Effect of transdermally administered hyoscine methobromide on nocturnal acid secretion in patients with duodenal ulcer. Br Med J (Clin Res Ed) (1982) 0.98
Peptic ulcer healing with ranitidine in cimetidine resistance. Lancet (1982) 0.98
Localization of cholecystokinin A and cholecystokinin B-gastrin receptors in the human stomach. Gastroenterology (1997) 0.97
[Tumors and eosinophilic granuloma of the small intestine in malabsorption]. Schweiz Med Wochenschr (1974) 0.97
Evidence that adaptive cytoprotection in rats is not mediated by prostaglandins. Gastroenterology (1988) 0.97
Combined surgical and interventional radiological approach for complex benign biliary tract obstruction. Br J Surg (1991) 0.97
Optimizing acid suppression for treatment of acid-related diseases. Dig Dis Sci (1995) 0.96
Tolerance to oral H2-receptor antagonists. Dig Dis Sci (1990) 0.95
The cephalic and gastric phases of gastric secretion during H2-antagonist treatment. Gastroenterology (1991) 0.93
Nonsteroidal antiinflammatory drug-induced colonic strictures: a case report. Gastroenterology (1991) 0.92
Loss of acid suppression during dosing with H2-receptor antagonists. Aliment Pharmacol Ther (1990) 0.92
Prostaglandins for peptic ulcer: a promise unfulfilled. Lancet (1986) 0.92
[Different healing tendencies of reflux esophagitis following omeprazole and ranitidine. Results of a German-Austrian-Swiss multicenter study]. Dtsch Med Wochenschr (1986) 0.92
Trophic effect on longterm administration of 16,16-dm PGE2 on the rat gastric and duodenal mucosa. Scand J Gastroenterol Suppl (1982) 0.92
Use of automatic computerised pump to maintain constant intragastric pH. Gut (1990) 0.92
Antacid provides better restoration of glandular structures within the gastric ulcer scar than omeprazole. Gut (1994) 0.91
24-hour intragastric pH: continuous monitoring or nasogastric aspiration? Digestion (1986) 0.91
Early evening ranitidine administration promotes faster duodenal ulcer healing. Am J Gastroenterol (1988) 0.90
Intragastric pH monitoring in acute upper gastrointestinal bleeding and the effect of intravenous cimetidine and ranitidine. Aliment Pharmacol Ther (1987) 0.90
Omeprazole heals duodenal, but not gastric ulcers more rapidly than ranitidine. Results of two German multicentre trials. Hepatogastroenterology (1985) 0.90
[Short-term therapy of duodenal ulcer with omeprazole and ranitidine. Results of a German multicenter study]. Dtsch Med Wochenschr (1985) 0.90
Effects of prolonged administration of metiamide on serum gastrin, gastrin content of the antrum and gastric corpus, and G-cell population in the rat. Gastroenterology (1979) 0.89
Testing to check success of treatment to eradicate H pylori. Routine retesting is necessary. BMJ (1996) 0.89
Omeprazole and liver function tests. Lancet (1983) 0.88
Devastating diarrhoea caused by azathioprine: management difficulty in inflammatory bowel disease. Gut (1988) 0.88
Persistent lack of somatostatin receptors in gastric mucosa of healing ulcers in rats. Gastroenterology (1994) 0.88
Dissolution of gallstones by perfusion with Capmul via a catheter introduced endoscopically into the bile duct. N Engl J Med (1980) 0.88
[The behavior of dying patients]. Med Klin (1971) 0.87
Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole. Aliment Pharmacol Ther (1994) 0.86
Effects of pinaverium bromide and verapamil on the motility of the rat isolated colon. Br J Pharmacol (1985) 0.86
Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis. Aliment Pharmacol Ther (2001) 0.85
Estimation of the biliary excretion of different cephalosporins utilizing retrograde cholangio-pancreatography (ERCP). Endoscopy (1981) 0.85
Comparison of gastrointestinal loss of alpha-1-antitrypsin and chromium-51-albumin in Ménétrier's disease and the influence of ranitidine. Digestion (1983) 0.85
Sensitivity of the parietal cell to pentagastrin in health and duodenal ulcer disease: a reappraisal. Scand J Gastroenterol (1982) 0.85
Morphine-like action of enkephalin analog FK 33-824 on motility of the isolated rat colon. J Pharmacol Exp Ther (1981) 0.85
Cigarette smoking, gastric acidity and peptic ulceration. What are the relationships? Dig Dis Sci (1990) 0.85